-
Most Recent
Search Results
240 results for icgn
Ocugen Now Relies Solely on a Continued Covid-19 Crisis
OCGN stock is a mix of irrational exuberance related to its valuation, unrealistic hopes, continuous speculation and very poor fundamentals.
Is Approval Even Enough for Ocugen Stock?
Ocugen’s partner has shown promise with its Covid-19 vaccine. But with Ocugen getting just 45% of U.S. profits, that promise is priced into OCGN stock.
Ocugen Should Hit $9 If Its Covid-19 Vaccine Gets Approved
Ocugen still hopes its Covid-19 vaccine gets approved to start making revenue. OCGN-stock could be worth as much as $9.09 or 19% over today’s price…
Ocugen Could Still Be Undervalued If Its Covid-19 Vaccine Gets OK
Ocugen could still be undervalued if the FDA approves its Covid-19 vaccine. OCGN could be worth as much as $12.73 per share, 24% higher, using…
This Is No Time to Be Speculating on Ocugen
Ocugen’s ambitions are not gaining traction in an environment where most biotech investors are focusing on Covid-19. Thus, the case for OCGN stock is unusually…
Ocugen Stock Is Nothing More than a Risky Trade on Even-riskier Biotech
Ocugen gave rise to OCGN stock through a reverse merger with Histogenics. But despite this confusing deal, it really didn’t do much for either company…
Ocugen Stock Looks Like a Really Good Short Candidate Here
There’s a good deal of downside risk, but Ocugen is worth a look. OCGN stock is likely to fall as Ocugen raises $30 million or…
If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing
In this crazy Reddit-driven stock market, it’s still important to understand why OCGN stock is hot. And why it’s dangerous.
OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today
OCGN stock is pulling back after a muted earnings report this morning, as Ocugen makes a big bet on Covaxin for kids.
OCGN Stock: 2 Big Reasons Ocugen Shares Are Soaring Today
OCGN stock is on the move today thanks to two big headlines about its Covid-19 vaccine plans. Here’s what to know.
Take Profits If You Own Ocugen Stock, but Now’s Not the Time to Buy
As Ocugen has a long way to go to get approval from the FDA and commercialize Covaxine, OCGN stock will not likely to reach new…
Read the Label Carefully Before Gambling on Ocugen Stock
OCGN stock has tempted many speculators recently with its high-flying acrobatics. But you’ll want to read the label on Ocugen very carefully before even thinking…
Ocugen Needs Too Much Time and Too Much Cash
OCGN stock has held up despite the failure of what was its flagship drug. The remaining pipeline simply isn’t strong enough for investors to risk…
Ocugen Is a Crisis Trade That Just Might Pan Out
OCGN stock is risky yet the underlying science behind its Covid-19 vaccine combined with a messy situation in the U.S. bodes well.
OCGN Stock Alert: What Is Going on With Red-Hot Ocugen Today?
Investors are in a speculative frenzy around COVAXIN ahead of a WHO meeting tomorrow. OCGN stock is rallying as a result.
Consider Buying Range-Bound Apple Stock Before It Reaches New Highs
Although Apple is one of the consumer technology icons, AAPL stock is likely to be range-bound in the coming weeks.
OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial
OCGN stock fell into the red despite Ocugen’s success in advancing a regenerative cell therapy product evaluation.
Thinking Beyond EVs Will Boost Ford Motor Company Stock
It’s not a reason in and of itself to buy Ford stock, but the Detroit icon is finally thinking proactively about the future.
Google Internet Service Should Scare AT&T and Verizon
Google says it’s not looking to become a threat to wireless icons AT&T and Verizon, but that’s tough to believe.
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.
YHOO Stock: Yahoo! Inc. Is Just Waiting It Out
For all intents and purposes, the once-iconic Yahoo (YHOO) and its shareholders are now just waiting on the inevitable.
8 – 10 of 240 results
